TUBITAK Martek Technopark Company News: Global Brand in Generic Medicines CT Pharma Research
Click for PDF document.

Global brand in generics: CT Pharma Research

CT Pharma Research, one of the specialist brands in the generic drug market, is known as the solution partner of pharmaceutical companies seeking trust and quality. The company, which provides consultancy support to its customers, takes the pulse of the sector with its R&D sensitivity and high efficiency productions.

CT Pharma Research, a company that has many years of experience in the pharmaceutical industry in Türkiye and the Middle East, supports industry companies with special solutions in the field of pharmaceutical technology.

One of the expert company of TÜBİTAK Marmara Teknokent's, CT Pharma Research, produces special solutions for its customers and offers CT quality to pharmaceutical companies seeking trust and experience with its structure, R&D sensitivity, pharmaceutical patent applications, product improvement and development professionalism are pointed out in the sector.

CT Pharma Research, whose General Manager is Dr. Şerhan Şimşek, offers solutions to companies that do not have an R&D department that will create new products in a competitive environment.

 

Competitive in the generic market

CT Pharma Research, provides strategic consultancy for pharmaceutical companies to enrich their portfolios, develops the most suitable choices for the portfolio by analyzing the market, and provides optimum support to companies in this trend, carries out R&D studies for companies that do not have an R&D department and technical services.

CT Pharma Research, which develops generic products of original products when the patent expired, actively strives to develop the Turkish generics market, which is 60 percent cheaper than original drugs.

In addition to developing conventional generic drugs, CT Pharma Research also develops peptide-containing biotechnological products.

 

From formulation to production area…

The company, which provides full services at all stages from the development process of the preferred equivalent product to its transfer to the pilot production area, also pioneered the establishment of its own factory by one of its customers.

By supporting its consultancy services with new value-added products, CT Pharma takes the success steps in the sector with KAUS in Saudi Arabia.

(King Abdullah University Science and Technology) is taking firm steps forward as the first Turkish company with an office opening project.